If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPacific Global Regulatory News (PCH)

Share Price Information for Pacific Global (PCH)

Share Price is delayed by 15 minutes
Get Live Data
1.20    0.00 (0.00%)
Bid:
1.00
Ask:
1.40
Spread: 0.40 (40.00%)
Market Cap: £950.57k
PCH Live PriceLast checked at - London Stock Exchange

Intraday Pacific Global Share Chart

Form 8.3 - Pochin

29 Jan 2014 11:40

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Identity of the person whose positions/dealings are being disclosed: Computershare Trustees (Jersey) Limited as Trustee of the Pochin’s Plc Employees’ Share Trust
(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient

Computershare Trustees (Jersey) Limited re 2029854
(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Pochin’s Plc
(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:
(e) Date position held/dealing undertaken: 9 December 2013
(f) Has the discloser previously disclosed, or are they today disclosing, under the Code in respect of any other party to this offer? NO

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security:

Interests Short positions
Number % Number %
(1) Relevant securities owned and/or controlled: 440,500 2.12%
(2) Derivatives (other than options):
(3) Options and agreements to purchase/sell:

TOTAL:

All interests and all short positions should be disclosed.

Details of any open derivative or option positions, or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other executive options)

Class of relevant security in relation to which subscription right exists:
Details, including nature of the rights concerned and relevant percentages:

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

(a) Purchases and sales

Class of relevant security Purchase/sale Number of securities Price per unit

(b) Derivatives transactions (other than options)

Class of relevant security Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities Price per unit

(c) Options transactions in respect of existing securities

(i) Writing, selling, purchasing or varying

Class of relevant security Product description e.g. call option Writing, purchasing, selling, varying etc. Number of securities to which option relates Exercise price per unit Type

e.g. American, European etc.

Expiry date Option money paid/ received per unit

(ii) Exercising

Class of relevant security Product description

e.g. call option

Number of securities Exercise price per unit

(d) Other dealings (including subscribing for new securities)

Class of relevant security Nature of dealing

e.g. subscription, conversion

Details Price per unit (if applicable)

The currency of all prices and other monetary amounts should be stated.

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

If there are no such agreements, arrangements or understandings, state “none”

None

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state “none”

None

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached? NO
Date of disclosure: 9 December 2013
Contact name: Lee Ball
Telephone number: 01534 281 883

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s dealing disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

Copyright Business Wire 2014

Date   Source Headline
20th Nov 20077:01 amRNSInterim Management Statement
30th Oct 200711:18 amRNSDirectorate Change
22nd Oct 200712:32 pmRNSAnnual Information Update
24th Sep 20079:53 amRNSFinal Results - Replacement
24th Sep 20077:01 amRNSFinal Results
19th Jul 20074:23 pmRNSDirector/PDMR Shareholding
14th Jun 20072:30 pmRNSDirector/PDMR Shareholding
12th Jun 20075:20 pmRNSDirector/PDMR Shareholding
11th May 20075:46 pmRNSDirector/PDMR Shareholding
4th Apr 20074:37 pmRNSDirector/PDMR Shareholding
3rd Apr 20075:25 pmRNSDirector/PDMR Shareholding
29th Mar 20073:31 pmRNSHolding(s) in Company
27th Mar 20076:03 pmRNSDirector/PDMR Shareholding
27th Mar 20075:10 pmRNSHolding(s) in Company
27th Mar 20074:28 pmRNSHolding(s) in Company
26th Mar 20075:23 pmRNSDirector/PDMR Shareholding
22nd Mar 20079:14 amRNSHolding(s) in Company
21st Mar 20071:09 pmRNSDirector/PDMR Shareholding
20th Mar 20073:56 pmRNSHolding(s) in Company
20th Mar 20072:10 pmRNSDirector/PDMR Shareholding
8th Mar 20076:11 pmRNSDirector/PDMR Shareholding
5th Mar 200711:23 amRNSDirector/PDMR Shareholding
5th Mar 200711:23 amRNSDirector/PDMR Shareholding
27th Feb 20073:21 pmRNSInterim Dividend Record Date
27th Feb 20077:03 amRNSInterim Results
3rd Jan 20073:27 pmRNSDirectorate Change
21st Dec 200610:36 amRNSDirector/PDMR Shareholding
14th Dec 20063:37 pmRNSTotal Voting Rights
13th Dec 20063:42 pmRNSDirector/PDMR Shareholding
2nd Nov 20066:05 pmRNSDirector/PDMR Shareholding
2nd Nov 20065:56 pmRNSDirector/PDMR Shareholding
31st Oct 20064:02 pmRNSDirector/PDMR Shareholding
26th Oct 20063:57 pmRNSDirector/PDMR Shareholding
25th Oct 20064:23 pmRNSDirector/PDMR Shareholding
25th Oct 200610:00 amRNSAnnual Information Update
24th Oct 20063:29 pmRNSDirector/PDMR Shareholding
13th Oct 20064:18 pmRNSDirector/PDMR Shareholding
29th Sep 20068:11 amRNSFinal Results
23rd Aug 20065:05 pmRNSDirector/PDMR Shareholding
7th Aug 20062:55 pmRNSDirectorate Change
1st Jun 20065:26 pmRNSDisposal
12th May 20062:50 pmRNSDirector/PDMR Shareholding
16th Mar 200611:27 amRNSDirector/PDMR Shareholding
27th Feb 20065:30 pmRNSDividend Declaration
27th Feb 20067:01 amRNSInterim Results
24th Feb 20067:01 amRNSImplementation of IFRS PartII
24th Feb 20067:01 amRNSImplementation of IFRS Part I
3rd Jan 20063:19 pmRNSDirectorate Change
21st Dec 20053:41 pmRNSDirector/PDMR Shareholding
20th Dec 20059:09 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.